Dr. Sameer A. Siddiqui, MD

Dr. Siddiqui practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Siddiqui's NPI, 1366414864, was assigned on February 7, 2006. Dr. Siddiqui graduated from University of Missouri, Columbia School of Medicine in 2002. Dr. Siddiqui holds Missouri license 2009034594.

Dr. Siddiqui's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Siddiqui's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. Dr. Siddiqui is also affiliated with SSM Health St. Mary's Hospital - St. Louis. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Siddiqui to 2 more hospitals and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Siddiqui practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Siddiqui's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Siddiqui is licensed in Missouri.

CMS data shows 89 Medicare services from Dr. Siddiqui across 3 procedure codes in 2024, all of them office visits, for 109 Medicare patients. Medicare paid $6,365 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 109 Medicare patients who saw Dr. Siddiqui in 2024. The largest group is 65 to 74, with 55 patients. 73% of them have high blood pressure, and 61% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Siddiqui's median patient age at 69, with 11% women.

In 2024, Dr. Siddiqui wrote 175 Medicare Part D claims for 62 patients. 82% of them were for generic drugs. CMS names the drug for 119 of them, across 4 drugs with 11 or more claims each, at $22,996 in total drug cost. In 2023, CMS named 122 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Siddiqui for performance year 2024, reported as part of a group. Dr. Siddiqui accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Siddiqui as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 36 papers to Dr. Siddiqui, published from 2010 to 2022. 2019 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms, Kidney Neoplasms and Nephrectomy. Dr. Siddiqui has published most often in Can J Urol. Dr. Siddiqui's most frequent co-authors are Oussama Darwish, MD, James O. Peabody, MD and Justin Michael Barnes, MD, MS.

CMS Open Payments shows 168 general payments to Dr. Siddiqui from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Profound Medical Corp. paid the most, $2,340.

Dr. Siddiqui graduated from University of Missouri, Columbia School of Medicine in 2002.